Hyderabad, October 17 (Udaipur Kiran): Shares of Novelix Pharmaceuticals surged nearly 5% on Friday, hitting the upper circuit limit of ₹44.15, after the company announced signing a Technology Transfer Agreement with Germany-based GMBU e.V. to advance large-scale production of Astaxanthin, a powerful antioxidant used in nutraceutical and pharmaceutical applications.
The stock opened at ₹44.15 and remained locked at the day’s high and low of ₹44.15, up by ₹2.10 or 4.99% from its previous close of ₹42.05 on the BSE. A total of 20,826 shares were traded on the counter.
The BSE ‘X’ group stock, with a face value of ₹10, has touched a 52-week high of ₹52.79 on July 15, 2025, and a 52-week low of ₹21.91 on November 4, 2024. The company’s market capitalization stands at ₹63.93 crore. Over the past week, it traded between ₹44.15 and ₹38.00.
Promoters hold 52.75% of the company’s equity, while non-institutional investors own the remaining 47.25%.
Under the newly signed agreement, GMBU e.V. will transfer its proprietary technology and provide technical expertise for the cultivation and scale-up of Haematococcus pluvialis — a microalgae used in Astaxanthin production — to Novelix’s advanced research facility at BTIC Park, Genome Valley, Hyderabad.
As part of the collaboration, Novelix will fund and support the complete technology transfer process, including supply of algal strains, growth media, lab equipment, and infrastructure. The company will also set up a GMP-certified manufacturing facility at its Techno Park site in Hyderabad for bulk production of Astaxanthin aimed at European, North American, and Indian markets.
Novelix Pharmaceuticals is an innovation-driven biopharmaceutical firm based in Hyderabad, focused on developing novel therapeutics, advanced biologics, and nutraceutical solutions for global health applications.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.